Search Results

You are looking at 1 - 9 of 9 items for

  • Author: C Findlay x
  • Refine by access: All content x
Clear All Modify Search
S C Riley
Search for other papers by S C Riley in
Google Scholar
PubMed
Close
,
J K Findlay
Search for other papers by J K Findlay in
Google Scholar
PubMed
Close
, and
L A Salamonsen
Search for other papers by L A Salamonsen in
Google Scholar
PubMed
Close

Abstract

Previous studies have demonstrated that endothelin is present in the ovine endometrium and increases at around the expected time of implantation. To characterize further uterine endothelin at the time of establishment of pregnancy in sheep, endothelin was measured by radioimmunoassay in uterine flushings obtained during the oestrous cycle and in pregnant ewes up to the time of implantation (day 16). During the oestrous cycle, the highest amounts of endothelin were present in uterine flushings on day 14 (1·1 ±0·2 ng endothelin/uterus). During early pregnancy, basal levels of endothelin (0·5–0·6 ng endothelin/uterus) were present in uterine flushings for the first 10 days and then increased on day 14 to levels similar to those found at the equivalent stage of the oestrous cycle. On days 15 and 16 of pregnancy, endothelin content in the uterine lumen increased to significantly (P<0·05) higher concentrations (2·9±0·4 ng endothelin/uterus) when compared with the non-fertile cycle. The principal isoform present in flushings at the time of implantation was endothelin-1, as determined by reverse-phase HPLC. Endothelin was released principally by purified endometrial epithelial cells in culture, with barely detectable amounts released by endometrial stromal cells or conceptus tissue, which is consistent with the epithelium being the principal source of endothelin in the uterine lumen. Endothelin binding sites were present in endometrium and myometrium, as demonstrated by specific binding of 125I-labelled endothelin-1, which was saturable and displaced by endothelin-1. Both endothelinA and B sub-types of receptors were present as demonstrated by the biphasic displacement of 125I-labelled endothelin-1 binding by the specific endothelinB agonist BQ3020. These were localised principally on luminal and glandular epithelium and in the vasculature of the endometrium and myometrium as shown by autoradiography. Endothelin receptors were also present on the conceptus obtained at the time of implantation. In the day 20 conceptus, endothelin immunostaining was localised principally in the heart, in trophoblast in uninucleate but not in binucleate cells, and in fetal membranes. This immunostaining of the conceptus may represent binding to receptor sites. It is concluded that endothelin-1 is present in the uterine lumen and may play an important role in the paracrine regulation of the conceptus and endometrium at the time of rapid embryo development, implantation and early placentation.

Journal of Endocrinology (1995) 147, 235–244

Restricted access
RA Metcalfe
Search for other papers by RA Metcalfe in
Google Scholar
PubMed
Close
,
C Findlay
Search for other papers by C Findlay in
Google Scholar
PubMed
Close
,
WR Robertson
Search for other papers by WR Robertson in
Google Scholar
PubMed
Close
,
AP Weetman
Search for other papers by AP Weetman in
Google Scholar
PubMed
Close
, and
S Mac Neil
Search for other papers by S Mac Neil in
Google Scholar
PubMed
Close

The thyroid-stimulating hormone (TSH) binds to a receptor which activates adenylate cyclase and elevates cAMP concentration. In addition, effects of TSH on intracellular calcium and inositol phosphate accumulation have been reported. However, the mechanism of TSH-stimulated accumulation of inositol phosphates and elevation of calcium levels is unresolved. Previous work from this laboratory has shown TSH to cause acute transient increases in intracellular calcium in pig, human and FR TL-5 rat thyroid cells as well as in cell transfected with the human TSH receptor (JPO9 cells) in some (but not all) experiments. The aim of this study was to investigate the variability of the calcium response to TSH in JPO9 cells to learn more about the nature of this calcium signal induction. Calcium responses to TSH were determined using the fluorochrome fura-2 in both monolayers of adherent cells and adherent single cells. The responses to a single addition and to repetitive additions of TSH were compared. We also determined the cAMP response to TSH using these two protocols of TSH addition. Our data show that, whereas the cAMP response to TSH is highly predictable and consistent and does not require multiple exposures to TSH, cells were unlikely to respond to TSH with an increase in calcium unless they received multiple challenges with the hormone. A single addition of 10 mU/ml TSH failed to increase calcium in any of 40 single cells examined and in only 4 of 15 monolayers of cells (27%) examined; in contrast, 10 of 12 monolayers eventually responded with an increase in calcium after multiple exposure to TSH and 18 of 67 single cells. Similar data were obtained whether calcium was measured in single cells or in populations of cells. We also demonstrated cooperativity between an adenosine derivative, N6-(L-2-phenylisopropyl)adenosine, and TSH such that their co-administration resulted in a consistent and marked elevation in calcium levels not achieved with either agonist alone. In summary, we suggest that the coupling between the TSH receptor and the intracellular signalling system that leads to activation of intracellular calcium in JPO9 cells requires repetitive stimulation or the influence of other agonists, in contrast with the coupling between the TSH receptor and activation of the adenylate cyclase enzyme.

Free access
H. M. RADFORD
Search for other papers by H. M. RADFORD in
Google Scholar
PubMed
Close
,
C. D. NANCARROW
Search for other papers by C. D. NANCARROW in
Google Scholar
PubMed
Close
, and
J. K. FINDLAY
Search for other papers by J. K. FINDLAY in
Google Scholar
PubMed
Close

Prostaglandin analogues were used to induce luteal regression simultaneously in a number of ewes, thereby synchronizing the final stages of follicular maturation in these animals. Some of the ewes were anaesthetized for 24 h immediately after the injection of prostaglandin (experiment 1), and others for 15 h, starting 24 h after the injection of prostaglandin (experiment 2). In both experiments administration of anaesthetic significantly delayed the onset of oestrus and the time of ovulation relative to prostaglandin-treated control animals. The results from assays of blood samples collected at regular intervals in experiment 1 indicated that the preovulatory peak in the concentration of LH and the periovulatory changes in the concentration of FSH were similarly delayed and that during anaesthesia the level of LH was significantly reduced. It is suggested that the reduced level of LH, which probably resulted from a reduction in the secretion of releasing factor due to anaesthesia, failed to support oestrogen production by the Graafian follicle(s), thereby delaying the occurrence of oestrus and ovulation.

Restricted access
C L Adam
Search for other papers by C L Adam in
Google Scholar
PubMed
Close
,
P A Findlay
Search for other papers by P A Findlay in
Google Scholar
PubMed
Close
,
C E Kyle
Search for other papers by C E Kyle in
Google Scholar
PubMed
Close
,
P Young
Search for other papers by P Young in
Google Scholar
PubMed
Close
, and
J G Mercer
Search for other papers by J G Mercer in
Google Scholar
PubMed
Close

Abstract

Castrate male sheep (wethers, average liveweight 38 ± 0·6 kg) were given one of the following diets for 10 weeks followed by euthanasia (n=8/group): high-energy high-protein providing 1·5 times the energy required to maintain liveweight (maintenance) (group 1·5M), low-energy low-protein at 0·5 maintenance (0·5M), or low-energy high-protein at 0·5 maintenance (0·5M+P). 1·5M wethers gained 22% liveweight whereas 0·5M and 0·5M+P wethers lost 18 and 13% liveweight respectively. Relative to the 1·5M group, the 0·5M and 0·5M+P groups had similar plasma concentrations of glucose and cortisol throughout, but elevated non-esterified fatty acids (P<0·001) and reduced IGF-I and insulin (P<0·05, 0·01 or 0·001) from 1 week onwards. Each week blood samples were taken every 12 min for 4 h and plasma assayed for LH. Mean concentration over 4 h, LH pulse frequency and LH pulse amplitude showed no progressive change in 1·5M sheep. However, in both 0·5M and 0·5M+P groups mean LH increased (P<0·001 and P<0·01 respectively), pulse frequency decreased (P<0·01 and P<0·01) and pulse amplitude increased (P<0·001 and P<0·01) over the 10-week period. Anterior pituitary LH content was greater in 0·5M (P<0·01) and 0·5M+P (P<0·05) than in 1·5M sheep. Coronal sections (20 μm) of hypothalamic brain tissue were subjected to in situ hybridisation to determine gene expression for neuropeptide Y (NPY). NPY mRNA was concentrated in the arcuate nucleus and median eminence, with total amounts greater in both 0·5M (310%, P<0·001) and 0·5M+P (333%, P<0·01) groups than in 1·5M sheep (100%). These data reveal that chronic low dietary energy intake by long-term castrates, with high or low protein intake, reduces LH pulse frequency but increases the circulating levels of LH by virtue of an increase in pulse amplitude, and concomitantly increases hypothalamic NPY gene expression.

Journal of Endocrinology (1997) 152, 329–337

Restricted access
RA Ajjan
Search for other papers by RA Ajjan in
Google Scholar
PubMed
Close
,
PF Watson
Search for other papers by PF Watson in
Google Scholar
PubMed
Close
,
C Findlay
Search for other papers by C Findlay in
Google Scholar
PubMed
Close
,
RA Metcalfe
Search for other papers by RA Metcalfe in
Google Scholar
PubMed
Close
,
M Crisp
Search for other papers by M Crisp in
Google Scholar
PubMed
Close
,
M Ludgate
Search for other papers by M Ludgate in
Google Scholar
PubMed
Close
, and
AP Weetman
Search for other papers by AP Weetman in
Google Scholar
PubMed
Close

Iodide concentration by the thyroid gland, an essential step for thyroid hormone synthesis, is mediated by the Na+/I- symporter (NIS). To identify factors that may regulate this process, we have studied NIS gene expression in the Fisher rat thyroid cell line (FRTL-5) by a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) technique. Increasing concentrations of bovine TSH (0.1, 1, 10, 50 and 100 mU/l), with or without tumour necrosis factor-alpha (TNF alpha), interferon-gamma (IFN gamma) or interleukin-1 alpha (IL-1 alpha) were added to FRTL-5 cells previously deprived of TSH for a minimum of 5 days. RNA was extracted and samples were studied for NIS expression. TSH enhanced NIS mRNA expression in a dose-dependent manner, with induction evident at 0.1 mU/l, reaching a peak at 50 mU/l, an effect detected after 6 h of stimulation, but not in the first 2 h. Both TNF alpha and, to a lesser extent, IL-1 alpha inhibited basal and TSH-induced NIS expression. High concentrations of IFN gamma also downregulated TSH-stimulated NIS mRNA expression. Using the same technique, we also investigated NIS mRNA tissue distribution in two male and one female Wistar rats. High levels of NIS expression were detected in the thyroid, stomach, and mammary gland, lower levels were found in the intestine, adipose tissue and liver, borderline levels were expressed in the salivary gland, and no expression was detected in the kidneys. In summary, we have shown that TSH upregulates rat NIS gene expression in vitro, and this induction can be modulated by cytokines. Analysis of the distribution of rat NIS mRNA ex vivo demonstrated variable levels of NIS transcription in different tissue samples.

Free access
Z A Archer
Search for other papers by Z A Archer in
Google Scholar
PubMed
Close
,
S M Rhind
Search for other papers by S M Rhind in
Google Scholar
PubMed
Close
,
P A Findlay
Search for other papers by P A Findlay in
Google Scholar
PubMed
Close
,
C E Kyle
Search for other papers by C E Kyle in
Google Scholar
PubMed
Close
,
M C Barber
Search for other papers by M C Barber in
Google Scholar
PubMed
Close
, and
C L Adam
Search for other papers by C L Adam in
Google Scholar
PubMed
Close

Nutritional feedback provided by systemic hormones, such as insulin and leptin, influences reproductive neuroendocrine output within the hypothalamus, yet the mechanisms and their interaction with photoperiodic cues remain unresolved in seasonal species. Here, peripheral glucose (G) infusion was used to increase endogenous concentrations of insulin and leptin in food-restricted sheep kept in either long-day (LD) or short-day (SD) photoperiod, and responses were examined in terms of pulsatile luteinising hormone (LH) (gonadotrophin-releasing hormone by inference) output and hypothalamic gene expression for nutritionally sensitive neuropeptides and receptors. We addressed the hypothesis that these hypothalamic responses were correlated and influenced by photoperiod. Oestradiol-implanted, castrated male sheep were kept 16 weeks in SD (8 h light/day) or LD (16 h light/day) and then transferred to the opposite photoperiods for 8 weeks, during which food was restricted to 90% requirement to maintain body weight (maintenance). For the final 6 days, food was reduced to 75% maintenance, and sheep in both photoperiods were infused intravenously with G (60 mM/h) or saline (S) (n=8/group). G-infused sheep had higher mean plasma concentrations of G, insulin and leptin than S-infused sheep, with no effect of photoperiod. In LD, but not in SD, G infusion increased LH pulse frequency and pulse amplitude. In LD, but not in SD, gene expression in the hypothalamic arcuate nucleus was lower in G- than S-infused sheep for neuropeptide Y (NPY) and agouti-related peptide (AGRP) and was higher in G- than S-infused sheep for pro-opiomelanocortin (POMC). Gene expression for leptin and insulin receptors was not affected by photoperiod or infusion. These results are consistent with the involvement of NPY, AGRP and POMC in mediating the reproductive neuroendocrine response to increased systemic nutritional feedback, and they support the hypothesis that hypothalamic responses to nutritional feedback are influenced by photoperiod in sheep.

Free access
L.A. Salamonsen
Search for other papers by L.A. Salamonsen in
Google Scholar
PubMed
Close
,
S.J. Stuchbery
Search for other papers by S.J. Stuchbery in
Google Scholar
PubMed
Close
,
C.M. O'Grady
Search for other papers by C.M. O'Grady in
Google Scholar
PubMed
Close
,
J.D. Godkin
Search for other papers by J.D. Godkin in
Google Scholar
PubMed
Close
, and
J.K. Findlay
Search for other papers by J.K. Findlay in
Google Scholar
PubMed
Close

ABSTRACT

Ovine endometrial cells were isolated from ovariectomized oestrogen and progesterone-treated ewes and maintained in primary culture. In-vitro treatment with human interferon-α2 (Roferon, Hoffman La Roche) (5, 50 IU/ml) or purified ovine trophoblast protein 1 (oTP-1, 30 ng/ml) significantly attenuated PGF (25±17, 29±17, 28±9%±SEM of control [no in-vitro treatment = 100%] respectively, N=4 ewes) and PGE (11±4, 16±4, 16±5% of control) release from the cultured cells. Fluorography of two dimensional polyacrylamide gel electrophoretic analyses of proteins secreted by the cells following 35S-methionine incorporation, revealed that synthesis and secretion of the same "pregnancy-related" proteins was stimulated by both interferon-α2 and oTP-1. Thus, interferon-α2 (which has sequence homology with oTP-1) acts on the ovine endometrium, eliciting similar biological responses to those of oTP-1.

Restricted access
S. F. Beer
Search for other papers by S. F. Beer in
Google Scholar
PubMed
Close
,
P. M. M. Bircham
Search for other papers by P. M. M. Bircham in
Google Scholar
PubMed
Close
,
S. R. Bloom
Search for other papers by S. R. Bloom in
Google Scholar
PubMed
Close
,
P. M. Clark
Search for other papers by P. M. Clark in
Google Scholar
PubMed
Close
,
C. N. Hales
Search for other papers by C. N. Hales in
Google Scholar
PubMed
Close
,
C. M. Hughes
Search for other papers by C. M. Hughes in
Google Scholar
PubMed
Close
,
C. T. Jones
Search for other papers by C. T. Jones in
Google Scholar
PubMed
Close
,
D. R. Marsh
Search for other papers by D. R. Marsh in
Google Scholar
PubMed
Close
,
P. R. Raggatt
Search for other papers by P. R. Raggatt in
Google Scholar
PubMed
Close
, and
A. L. R. Findlay
Search for other papers by A. L. R. Findlay in
Google Scholar
PubMed
Close

ABSTRACT

Seventeen human subjects fasted without electrolyte replacement for 3 days and hormone levels were measured before, during and after the fast. Immediate consequences of the fasting state in healthy human subjects include a marked increase in plasma cortisol, ACTH, β-endorphin, β-lipotrophic hormone, adrenaline, noradrenaline and dopamine. Levels of all these hormones were much greater on the first morning of the fast than in the post-prandial state, even though the plasma glucose level was no lower than that observed on the morning before the fast began. A clear fall in TSH and tri-iodothyronine (T3) levels was observed, but thyroxine levels did not change significantly. Insulin levels fell whereas proinsulin levels did not fall during the fast, though they did rise markedly upon re-feeding. An increase in GH levels was particularly apparent in male subjects, but was also seen in females when evening samples were compared. Pancreatic glucagon showed a modest rise during the fast, but fell again on refeeding; total glucagon also rose as the fast proceeded, but increased markedly upon re-feeding. Levels of gastrin and peptide YY remained low during the fast. Plasma electrolyte levels were unchanged. The following were closely correlated: cortisol with ACTH, T3 with log10TSH, dopamine with noradrenaline, and (negatively, during the fast) pancreatic glucagon with glucose.

Journal of Endocrinology (1989) 120, 337–350

Restricted access
R.G. Forage
Search for other papers by R.G. Forage in
Google Scholar
PubMed
Close
,
R.W. Brown
Search for other papers by R.W. Brown in
Google Scholar
PubMed
Close
,
K.J. Oliver
Search for other papers by K.J. Oliver in
Google Scholar
PubMed
Close
,
B.T. Atrache
Search for other papers by B.T. Atrache in
Google Scholar
PubMed
Close
,
P.L. Devine
Search for other papers by P.L. Devine in
Google Scholar
PubMed
Close
,
G.C. Hudson
Search for other papers by G.C. Hudson in
Google Scholar
PubMed
Close
,
N.H. Goss
Search for other papers by N.H. Goss in
Google Scholar
PubMed
Close
,
K.C. Bertram
Search for other papers by K.C. Bertram in
Google Scholar
PubMed
Close
,
P. Tolstoshev
Search for other papers by P. Tolstoshev in
Google Scholar
PubMed
Close
,
D.M. Robertson
Search for other papers by D.M. Robertson in
Google Scholar
PubMed
Close
,
D.M. de Kretser
Search for other papers by D.M. de Kretser in
Google Scholar
PubMed
Close
,
B. Doughton
Search for other papers by B. Doughton in
Google Scholar
PubMed
Close
,
H.G. Burger
Search for other papers by H.G. Burger in
Google Scholar
PubMed
Close
, and
J.K. Findlay
Search for other papers by J.K. Findlay in
Google Scholar
PubMed
Close

ABSTRACT

Seven Merino–Border Leicester cross–bred ewes were immunized with a purified fusion protein, produced by recombinant DNA methods, of the a subunit of bovine inhibin. Four animals were immunized with the fusion protein alone and three with a conjugate made by coupling the fusion protein to keyhole limpet haemocyanin (KLH) using glutaraldehyde. Each animal received four injections of the fusion protein over 93 days. The animals were synchronized using progestagen sponges and subjected to laparoscopy for the determination of ovulation rates in two consecutive cycles (days 115 and 135). The immunized animals had overall mean ovulation rates for each cycle of 3.4 and 3.4 which was significantly (P < 0.001) above the rates of 1.1 and 1.4 determined for the controls, which had either received no treatment (n=5) or had been immunized with 300 μg KLH (n=4). Analysis of antisera taken on day 115 showed significant fusion protein antibodies and iodinated inhibin–binding capacity in the test but not control groups. Furthermore, antisera to the fusion protein in four out of seven ewes neutralized the inhibin bioactivity of ovine follicular fluid in an in–vitro bioassay. These data demonstrate that neutralization of inhibin can be effected by immunization with bovine inhibin a subunit and that such immunization results in increased ovulation rates as predicted from the biological role of inhibin as a suppressor of FSH.

Restricted access